(Q40929546)

24 September 2017

title

Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

26 June 2022

main subject

congestive heart failure

1 reference

W. S. Aronow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356598

26 June 2022

D. T. Danahy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A356598

26 June 2022

language of work or name

English

0 references

publication date

1 July 1978

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:0002934378907040?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

https://api.elsevier.com/content/article/PII:0002934378907040?httpAccept=text/plain

26 June 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

American Journal of Medicine

26 June 2022

published in

1 reference

24 September 2017

volume

65

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

155-160

1 reference

Improved left ventricular function during nitroprusside infusion in acute myocardial infarction

24 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction

6 April 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure

6 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Treatment of refractory heart failure with infusion of nitroprusside.

6 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance

6 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Vasodilator therapy in acute myocardial infarction. A comparison of sodium nitroprusside and nitroglycerin

6 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Use of Sublingual Nitroglycerin in Congestive Failure following Acute Myocardial Infarction

6 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.

6 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Hemodynamic effects of nitroglycerin in acute myocardial infarction

6 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure

6 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure

6 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Vasodilator therapy for chronic left ventricular failure

6 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: Prolonged effectiveness of isosorbide dinitrate

6 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction

6 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Combination vasodilator therapy for severe chronic congestive heart failure

6 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Oral hydralazine therapy for chronic refractory heart failure

6 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Phentolamine for vasodilator treatment of severe heart-failure

6 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Enhanced left ventricular performance with phentolamine in acute myocardial infarction.

6 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Use of phentolamine in acute myocardial infarction

6 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Hemodynamic effects of trimazosin in patients with left ventricular failure

6 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Effects of prazosin on forearm resistance and capacitance vessels

6 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

6 April 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, h

6 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Treatment of essential hypertension with trimazosin, a new vasodilator agent

6 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Comparison of trimazosin and methyldopa in hypertension

6 April 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension

6 April 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Prazosin: preliminary clinical and pharmacological observations

6 April 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Physiologic evaluation of a new antihypertensive agent: prazosin HCl

6 April 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure

6 April 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90704-0

6 April 2023

Identifiers

1 reference

24 September 2017

1 reference